E-LIB Suche - Ergebnisse für: Kucharzik, T.

1

P905 Symptomatic remission and IUS improvements in a multi-..:

Zeissig, S ; Schmelz, R ; Helwig, U...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1657-i1657 , 2024

2

P518 Safety of upadacitinib in ulcerative colitis: Long-ter..:

Panaccione, R ; Lichtenstein, G ; Nakase, H...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i644-i646 , 2023

Link: https://doi.org/10.1093/..

3

Monitoring of patients with active inflammatory bowel disea..:

Kucharzik, T. ; Verstockt, B. ; Maaser, C.
Frontiers in Gastroenterology. 2 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

P156 Submucosa hypertrophy of active UC patients suggests t..:

Kucharzik, T ; Helwig, U ; Strobel, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i316-i316 , 2023

Link: https://doi.org/10.1093/..

5

P181 IBD patients with early clinical and sonographic impro..:

Kucharzik, T ; Helwig, U ; Seibold, F...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i247-i248 , 2022

Link: https://doi.org/10.1093/..

6

P369 High prevalence of abdominal pain in Crohn's Disease p..:

Kugel, T ; Maaser, C ; Kucharzik, T...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S386-S387 , 2021

Link: https://doi.org/10.1093/..

7

ECCO Guidelines on the Prevention, Diagnosis, and Managemen..:

Kucharzik, T ; Ellul, P ; Greuter, T...
Journal of Crohn's and Colitis. 15 (2021) 6 - p. 879-913 , 2021

Link: https://doi.org/10.1093/..

8

P689 Patient-reported outcomes (PRO-2) and intestinal ultra..:

Maaser, C ; Helwig, U ; Fischer, I...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S560-S561 , 2020

Link: https://doi.org/10.1093/..

9

Inflammatory Bowel Disease Management During the COVID-19 O..:

Magro, F ; Rahier, J-F ; Abreu, C...
Journal of Crohn's and Colitis. 14 (2020) Supplement_3 - p. S798-S806 , 2020

Link: https://doi.org/10.1093/..

10

DOP10 Intestinal ultrasound response and transmural healing..:

Kucharzik, T ; Wilkens, R ; Maconi, G...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S046-S048 , 2020

Link: https://doi.org/10.1093/..

11

Neue Therapieoptionen bei moderater bis schwerer Colitis ul..:

Kucharzik, T. ; Nitschmann, S.
Der Internist. 61 (2020) 4 - p. 433-436 , 2020

Link: https://doi.org/10.1007/..

12

P176 Expert consensus on acquisition and reporting of intes..:

Wilkens, R T ; Nylund, K ; Petersen, F...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S225-S226 , 2020

Link: https://doi.org/10.1093/..

13

DOP57 Monitoring response to anti-TNF therapy in ulcerative..:

Maaser, C ; Petersen, F ; Helwig, U...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S063-S064 , 2019

Link: https://doi.org/10.1093/..

14

P424 Monitoring response to adalimumab therapy in Crohn's d..:

Kucharzik, T ; Maaser, C ; Helwig, U...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S319-S319 , 2018

Link: https://doi.org/10.1093/..

15

DOP001 Effectiveness and safety of vedolizumab in anti-TNF ..:

Kopylov, U ; Verstockt, B ; Biedermann, L...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S029-S030 , 2018

Link: https://doi.org/10.1093/..